drugset
drugset / Trial / NCT03864913

Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents

NCT03864913 ↗

Phase 0 Completed 26 enrolled Oregon Health and Science University
RandomizedParallel-groupOpen-labelTreatment

Summary

The trial studies the efficacy of subcutaneous (SQ) testosterone compared to intramuscular (IM) testosterone therapy during the first 6 months of pubertal induction in transgender male adolescents. Describes rate of adverse effects, masculinizing effects and quality of life while receiving testosterone. Evaluates clinic utilization required for testosterone therapy.

Timeline

Start
2018-01-26
Primary completion
2019-06-30
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule — Subcutaneous

Indications

No indication recorded.